Hani Al‐Salami
Impact in
- Pharmaceutical Science top 0.1%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Molecular Medicine top 2%
Papers in
- Surgery 60
- Pancreatic function and diabetes 54
-
- Advanced Drug Delivery Systems 43
- Drug Solubulity and Delivery Systems 20
- Co-authors
- Armin Mooranian (114 shared papers)Crispin R. Dass (31 shared papers)Momir Mikov (100 shared papers)Rebecca Negrulj (30 shared papers)Chun Yuen Jerry Wong (14 shared papers)Svetlana Goločorbin-Kon (46 shared papers)Marc Fakhoury (11 shared papers)Frank Arfuso (25 shared papers)
- Journals
- Therapeutic Delivery (25 papers)Pharmaceutics (10 papers)Artificial Cells Nanomedicine and Biotechnology (8 papers)Journal of drug targeting (7 papers)Frontiers in Pharmacology (6 papers)
- Partner nations
- AustraliaSerbiaNew Zealand
In The Last Decade
Hani Al‐Salami
210 papers receiving 5.9k citations
Hani Al‐Salami's Hit Papers
Peers
Comparison fields: 5 of 150
- Pharmaceutical Science 1.2k
- Molecular Medicine 230
- Biomaterials 633
- Endocrinology, Diabetes and Metabolism 706
- Sensory Systems 185
Countries citing papers authored by Hani Al‐Salami
This map shows the geographic impact of Hani Al‐Salami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hani Al‐Salami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hani Al‐Salami more than expected).
Fields of papers citing papers by Hani Al‐Salami
This network shows the impact of papers produced by Hani Al‐Salami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hani Al‐Salami. The network helps show where Hani Al‐Salami may publish in the future.
Co-authors
The 25 scholars most cited alongside Hani Al‐Salami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 215 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inflammatory bowel disease: clinical aspects and treatments Hit paper breakdown → | 2014 | 400 |
| 2 | 2018 | 240 | |
| 3 | 2017 | 229 | |
| 4 | 2017 | 213 | |
| 5 | 2017 | 134 | |
| 6 | 2017 | 131 | |
| 7 | 2020 | 121 | |
| 8 | 2008 | 118 | |
| 9 | 2018 | 104 | |
| 10 | 2018 | 99 | |
| 11 | 2020 | 96 | |
| 12 | 2020 | 90 | |
| 13 | 2018 | 84 | |
| 14 | 2020 | 76 | |
| 15 | 2020 | 70 | |
| 16 | 2017 | 69 | |
| 17 | 2008 | 65 | |
| 18 | 2014 | 62 | |
| 19 | 2014 | 60 | |
| 20 | The Influence of Intestinal Tract and Probiotics on the Fate of Orally Administered Drugs. | 2014 | 60 |
About Hani Al‐Salami
Hani Al‐Salami is a scholar working on Surgery, Pharmaceutical Science, Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism, having authored 215 papers that have together received 6.0k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (54 papers), Advanced Drug Delivery Systems (43 papers), Drug Transport and Resistance Mechanisms (29 papers), Cannabis and Cannabinoid Research (24 papers), Drug Solubulity and Delivery Systems (20 papers), Diabetes Management and Research (18 papers), Diabetes and associated disorders (14 papers) and RNA Interference and Gene Delivery (12 papers). The work is most often cited by research in Pharmaceutical Science (1.2k citations), Molecular Medicine (230 citations), Biomaterials (633 citations), Endocrinology, Diabetes and Metabolism (706 citations) and Sensory Systems (185 citations). Hani Al‐Salami has collaborated with scholars based in Australia, Serbia and New Zealand. Frequent co-authors include Armin Mooranian, Crispin R. Dass, Momir Mikov, Rebecca Negrulj, Chun Yuen Jerry Wong, Svetlana Goločorbin-Kon, Marc Fakhoury, Frank Arfuso, Ryusuke Takechi and Maja Đanić. Their work appears in journals such as Therapeutic Delivery, Pharmaceutics, Artificial Cells Nanomedicine and Biotechnology, Journal of drug targeting and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.